NCT01331421View on ClinicalTrials.gov

Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

August 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

exemestane

25 mg tablet

Trial Locations (1)

65802

BioKinetic Clinical Applications, Inc., Springfield

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01331421 - Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions | Biotech Hunter | Biotech Hunter